VOYA INVESTMENT MANAGEMENT LLC

Position in CMPX — Compass Therapeutics, Inc.

CIK 1068837 ATLANTA, GA

Position in CMPX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$1,985,441

+$1,863,924 QoQ

Shares Held

375,320

+1558.6% QoQ

Ownership

0.208%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,306,795,205 across 174 Biotechnology names. CMPX ranks #59 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	349,912	$270,356,007
2	VRTX	Vertex Pharmaceuticals Inc / Ma	527,047	$235,347,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	148,488	$49,130,223
4	PTGX	Protagonist Therapeutics, Inc	454,383	$47,891,967
5	ARWR	Arrowhead Pharmaceuticals, Inc.	656,129	$41,139,286
6	BBIO	BridgeBio Pharma, Inc.	538,980	$40,024,653
7	INSM	INSMED Inc	243,706	$39,850,804
8	SRRK	Scholar Rock Holding Corp	725,409	$35,661,105

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,985,441	375,320	+1558.6%	Shares	Defined	2026-05-12
2025-12-31	$121,517	22,629	+31.5%	Shares	Defined	2026-02-12
2025-09-30	$60,249	17,214	-36.6%	Shares	Defined	2025-10-09
2025-06-30	$70,613	27,159	-7.9%	Shares	Defined	2025-08-14
2025-03-31	$56,027	29,488	-9.4%	Shares	Defined	2025-06-18
2024-12-31	$47,213	32,561	-13.5%	Shares	Defined	2025-05-02
2024-09-30	$69,299	37,663	+31.3%	Shares	Defined	2025-02-07
2024-06-30	$28,689	28,689	-10.9%	Shares	Defined	2025-02-07
2024-03-31	$63,752	32,198	-18.6%	Shares	Defined	2025-02-07
2023-12-31	$61,707	39,556	0.0%	Shares	Defined	2025-02-07
2023-09-30	$77,925	39,556	+5.7%	Shares	Defined	2025-02-07
2023-06-30	$119,036	37,433	—	Shares	Defined	2025-02-07
No filing history on record for this holder in this stock.